Congratulations to NanoVation Therapeuticsâ,,� for winning Life Sciences of British Columbia's, Deal of the Year!

Congratulations to NanoVation Therapeutics™ for winning Life Sciences of British Columbia's, Deal of the Year! NanoVation has made a tremendous impact in the life sciences sector by partnering with Novo Nordisk to accelerate the development of innovative genetic medicines, pushing the boundaries of what’s possible in addressing some of the most challenging diseases. With approximately US$600M in upfront and milestone payments (and future royalties) – this is a testament to the global impact and potential of NanoVation’s technology.

For a further read:

NanoVation wins “Deal of the Year” award from Life Sciences BC

Life Sciences BC Announces 2025 Awards Winners, Honouring Excellence in Health Innovation